Losartan Cost in West Virginia 2026: Cash Price, Medicaid, and Savings Options

At a glance
- Cash-pay price / ~$10/month at WV retail pharmacies in 2026
- Branded Cozaar list price / ~$80/month (Merck)
- WV Medicaid coverage / Not currently on the preferred drug list
- Compounded losartan (503A) / Available via licensed WV-compliant pharmacies
- Telehealth prescribing / Legal in West Virginia
- Typical dose / 25 to 100 mg once daily oral tablet
- FDA-approved indications / Hypertension, diabetic nephropathy (type 2), stroke risk reduction in LVH
- GoodRx / SingleCare discount range / $8, $15/month at major WV chains
- Manufacturer savings card / Available for branded Cozaar; limited utility for most WV patients on generic
- Primary clinical trial / LIFE trial (Lancet 2002, N=9,193)
What Losartan Is and Why West Virginia Patients Use It
Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three indications: hypertension, reduction of stroke risk in patients with hypertension and left ventricular hypertrophy (LVH), and slowing the progression of diabetic nephropathy in patients with type 2 diabetes and proteinuria [1]. It works by selectively blocking the AT1 receptor, reducing vasoconstriction and aldosterone secretion.
West Virginia has the highest age-adjusted cardiovascular disease mortality rate in the United States, at 302.4 per 100,000 population according to CDC data [2]. Hypertension affects an estimated 43% of WV adults, well above the national average of 34% [3]. Those numbers make affordable ARB access a concrete public-health concern, not an abstract policy debate.
The LIFE trial (Losartan Intervention For Endpoint reduction in hypertension, N=9,193) compared losartan to atenolol over a mean follow-up of 4.8 years. Losartan reduced the composite of cardiovascular death, myocardial infarction, and stroke by 13% relative to atenolol (relative risk 0.87 to 95% CI 0.77, 0.98, P=0.021), with a notably larger 25% reduction in fatal and non-fatal stroke [4]. The American Heart Association notes ARBs as a first-line antihypertensive class alongside ACE inhibitors, thiazide diuretics, and calcium channel blockers [5].
The Kidney Disease: Improving Global Outcomes (KDIGO) 2024 clinical practice guideline states: "ARBs are the preferred renin-angiotensin system blockade in patients with type 2 diabetes and urine albumin-to-creatinine ratio >30 mg/g" [6]. Losartan 50 to 100 mg daily is the most commonly prescribed ARB in that setting.
Losartan Cash Price in West Virginia in 2026
Generic losartan costs approximately $10 per month at West Virginia retail pharmacies when purchased with a discount card. Without any card or coupon, the same 30-tablet supply of 50 mg losartan may run $18, $25 at independent pharmacies and $12, $20 at large chains such as CVS, Walgreens, Kroger, and Walmart.
The $10 figure reflects GoodRx, SingleCare, and RxSaver contract pricing at in-network West Virginia pharmacies. Walmart's $4/$10 generic program covers losartan potassium in many WV store locations, bringing a 90-day supply to roughly $10 total, less than $0.12 per day [7]. That is the single lowest price point available without a prescription assistance program.
Branded Cozaar (Merck) carries a manufacturer list price near $80 per month. Because high-quality generics have been on the market since 2010, prescribers and pharmacists in West Virginia almost universally substitute generic losartan potassium at the point of dispensing unless the patient specifically requests the brand. The FDA confirms therapeutic equivalence of all AB-rated generic losartan products [8].
A 2023 analysis in JAMA Network Open found that patients who used prescription discount cards for generic antihypertensives paid 64% less on average than patients who used insurance, because generic cash prices had fallen below most commercial plan copays [9]. That dynamic applies directly to losartan in West Virginia: your insurance copay tier may actually be higher than the GoodRx cash price.
Dose affects cost modestly. Losartan 25 mg, 50 mg, and 100 mg tablets are all similarly priced at retail, because pharmacies stock similar quantities and the pill cost dominates over active ingredient weight. Patients titrated to 100 mg daily should confirm the 100 mg tablet price rather than assuming a doubled 50 mg dose is cheaper.
West Virginia Medicaid Coverage for Losartan
West Virginia Medicaid does not currently list losartan on its preferred drug list (PDL) as a preferred agent. The WV Bureau for Medical Services PDL (updated quarterly) places several other ARBs and ACE inhibitors in preferred status, meaning losartan may require a prior authorization (PA) for Medicaid members [10].
This creates a practical gap. A PA for losartan under WV Medicaid typically requires documentation that the patient has tried and either failed or is contraindicated to a preferred ARB such as irbesartan or an ACE inhibitor such as lisinopril. Processing time is 3, 7 business days for standard PAs and 24 hours for urgent requests under West Virginia Medicaid policy.
Given that generic losartan costs $8, $10 cash-pay with a discount card, many WV Medicaid patients and their prescribers elect to bypass the PA process and pay out of pocket. This is worth calculating explicitly: a $10 cash-pay monthly expense may be preferable to a multi-week PA delay, particularly for a patient newly diagnosed with hypertension or diabetic nephropathy.
Patients enrolled in WV Medicaid managed care organizations (MCOs), including WV Family Health and The Health Plan, should check their specific MCO formulary, because MCO formularies can differ from the state PDL and are updated on different schedules [10].
Losartan and Private Insurance in West Virginia
Most commercial insurance plans available through the West Virginia Health Benefit Exchange (the ACA marketplace) place generic losartan on Tier 1 or Tier 2 of their formulary. Tier 1 copays at WV exchange plans range from $0 to $15 per 30-day fill. Tier 2 copays range from $10 to $45.
Employer-sponsored plans in West Virginia largely mirror that structure. United HealthCare, Highmark BCBS of WV, and Aetna all list generic losartan as a preferred generic in their standard WV formularies as of 2025 plan year data [11]. CareSource and Humana Medicaid plans in WV may apply different PA rules.
The practical check: log into your insurer's drug pricing tool with your specific plan ID, or call the pharmacy benefits number on the back of your insurance card. Compare that copay to the GoodRx price at your preferred pharmacy. Use whichever is lower. Under the Affordable Care Act, you are legally permitted to pay cash (not use your insurance) for any prescription, and doing so does not affect your deductible accumulation for other services.
Medicare Part D beneficiaries in West Virginia will find losartan covered on most Part D plans at the generic copay tier. During the coverage gap (historically the "donut hole"), generic drug cost-sharing was capped at 25% under the Inflation Reduction Act of 2022, reducing out-of-pocket exposure significantly [12].
Is Compounded Losartan Legal in West Virginia?
Compounded losartan prepared by a licensed 503A pharmacy is legal in West Virginia when dispensed pursuant to a valid patient-specific prescription from a licensed prescriber. Section 503A of the federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies [13]. West Virginia follows federal 503A requirements and enforces them through the West Virginia Board of Pharmacy.
A 503A pharmacy compounds losartan to order for a specific named patient. This differs from 503B outsourcing facilities, which can compound in bulk without a patient-specific prescription but must register with the FDA. West Virginia patients accessing losartan through telehealth-linked compounding programs typically receive product from 503A-compliant pharmacies.
Cost at 503A compounding pharmacies varies. In telehealth membership models, compounded losartan may be included in a monthly program fee, effectively making the drug cost $0 in direct out-of-pocket terms for the patient. Standalone compounding without a telehealth bundle generally runs $20, $45 per month depending on dose and formulation (oral solution vs. tablet).
The FDA has not placed losartan on the 503A bulk drug substances list, which means compounding is permissible but must be done from an FDA-registered active pharmaceutical ingredient (API) supplier. The West Virginia Board of Pharmacy conducts periodic inspections of in-state 503A pharmacies to verify compliance [14]. Patients should confirm that their compounding pharmacy holds a current WV Board of Pharmacy license before filling a compounded prescription.
One practical caveat: compounded drugs are not FDA-approved finished products. They lack the bioequivalence testing that generic manufacturers must complete. For a well-characterized small molecule like losartan potassium, this distinction is clinically minor for most patients. However, patients with absorption disorders or those requiring precise dose titration should discuss the formulation choice with their prescriber.
Telehealth Prescribing of Losartan in West Virginia
Telehealth prescribing of losartan is legal in West Virginia. The state enacted permanent telehealth flexibilities under WV Code §16-2I-1 et seq., allowing audio-video and, in defined circumstances, audio-only consultations for establishing a prescribing relationship [15].
Losartan is a Schedule-exempt medication. It is not a controlled substance under the DEA's Controlled Substances Act or West Virginia's Uniform Controlled Substances Act. This means a West Virginia-licensed prescriber can legally write a losartan prescription following a telehealth visit without any in-person examination requirement, provided the prescriber exercises appropriate clinical judgment and documents a valid patient-provider relationship.
A telehealth visit for hypertension management in West Virginia typically costs $49, $99 without insurance, or $0 copay under many ACA plans that cover preventive and primary care telehealth. Adding the $10 monthly drug cost brings the total first-month expense to under $110. Subsequent months cost only the drug price.
Blood pressure monitoring is the key clinical piece. The American Heart Association's 2017 guidelines (updated 2022) recommend home blood pressure monitoring with a validated device for all patients on antihypertensive therapy [16]. West Virginia telehealth providers routinely instruct patients to use an upper-arm cuff device (validated list maintained by the American Medical Association) and submit readings through a patient portal between visits.
West Virginia Losartan Discount Programs and Savings Cards
Several programs can reduce losartan cost below the already-low $10 cash price.
GoodRx and SingleCare. Free discount cards accepted at CVS, Walgreens, Kroger, Walmart, Rite Aid, and independent pharmacies statewide. GoodRx prices for losartan 50 mg (30 tablets) range from $8 to $15 at WV locations. No enrollment, no income requirement.
Walmart $4/$10 Generic Program. Losartan potassium 25 mg, 50 mg, and 100 mg are included. A 30-day supply costs $4; a 90-day supply costs $10. Available at all WV Walmart pharmacy locations [7].
Merck Patient Assistance Program (PAP). Merck offers branded Cozaar free or at reduced cost to uninsured or underinsured patients who meet income criteria (generally at or below 400% of the federal poverty level). Applications go through the Merck Helps program. Because generic losartan is so inexpensive, this program is most relevant for patients who specifically require branded Cozaar for a documented clinical reason.
NeedyMeds and RxOutreach. Two nonprofit programs that maintain databases of manufacturer PAPs and offer their own low-cost generic dispensing. Losartan appears in the RxOutreach formulary at a reduced cost for qualifying patients [17].
West Virginia CHIP and Children's Health Insurance. Pediatric patients with hypertension requiring losartan may qualify for coverage under WV CHIP, which has broader formulary access than adult Medicaid in some MCO contracts.
340B Program. Federally qualified health centers (FQHCs) and rural health clinics operating in West Virginia's many medically underserved counties participate in the 340B drug pricing program. Patients receiving care at a 340B-covered entity may access losartan at 340B contract pricing, which is significantly below retail [18]. West Virginia has 28 active 340B-covered entities as of 2024, concentrated in rural counties with the highest cardiovascular disease burden.
Dosing, Titration, and Monitoring Relevant to Cost Planning
Understanding the dosing trajectory matters because dose changes affect refill quantities and, occasionally, price.
Hypertension: starting dose is 50 mg once daily. Titration to 100 mg once daily occurs at 3 to 6 weeks if blood pressure remains above target (<130/80 mmHg per the AHA 2022 guideline) [16]. Some patients with volume depletion or those on diuretics start at 25 mg.
Diabetic nephropathy: the RENAAL trial (N=1,513) showed that losartan 50 to 100 mg daily reduced the risk of doubling of serum creatinine, end-stage renal disease, or death by 16% versus placebo (P=0.022) over a mean of 3.4 years [19]. Target dose in this indication is 100 mg daily.
Stroke risk reduction in LVH: the LIFE trial used a forced-titration protocol from 50 mg to 100 mg, with hydrochlorothiazide 12.5 to 25 mg added as needed [4].
Monitoring labs for losartan include serum potassium and creatinine at baseline, at 2 to 4 weeks after starting or changing dose, and at least annually thereafter. West Virginia patients with CKD (prevalent in the state given high rates of diabetes and hypertension) may need more frequent monitoring. A basic metabolic panel at a Quest or LabCorp facility in WV runs $25, $45 cash-pay, or is covered under most insurance plans as routine care.
Losartan is teratogenic and contraindicated in pregnancy. The FDA label carries a black box warning: "When pregnancy is detected, discontinue losartan as soon as possible" [1]. West Virginia providers prescribing losartan via telehealth routinely document pregnancy status and contraception plan at each visit.
How Losartan Compares to Other ARBs on Cost in West Virginia
Losartan is the lowest-cost ARB at WV pharmacies, largely because it was the first ARB to go generic (2010) and has the most manufacturers competing in the market.
Valsartan generic: $12, $18/month cash. Irbesartan generic: $15, $22/month. Olmesartan generic: $18, $30/month. Telmisartan generic: $20, $35/month. Candesartan generic: $22, $40/month.
All ARBs share a class-level contraindication in pregnancy and a risk of hyperkalemia, particularly in CKD. The 2022 ACC/AHA guideline notes no clinically meaningful difference in antihypertensive efficacy among ARBs at equivalent doses [20]. West Virginia prescribers who want to minimize patient cost while staying within ARB class have a clear first choice: losartan.
One situation favors a different agent. Patients with heart failure with reduced ejection fraction (HFrEF) and ACE inhibitor intolerance should receive sacubitril/valsartan (Entresto) rather than losartan, per the 2022 AHA/ACC heart failure guideline [21]. Entresto's cost profile is entirely different, the brand list price exceeds $600/month, and insurance coverage becomes the dominant access question in that setting.
Practical Step-by-Step Guide for West Virginia Patients
Getting losartan at the lowest possible price in West Virginia involves four concrete steps.
First, obtain a valid prescription. A telehealth visit with a WV-licensed provider is the fastest route. Providers at platforms operating in WV can assess blood pressure history, review prior labs, and issue a prescription in a single 15 to 20 minute visit.
Second, check GoodRx and Walmart pricing before going to the pharmacy. Pull up the GoodRx app, enter your zip code, and compare prices at the three or four nearest pharmacies. Print or screenshot the coupon.
Third, confirm whether your insurance copay beats the cash price. For most WV patients on a Tier 1 generic plan, the copay will be $0, $10. For patients with high-deductible plans who have not met their deductible, the cash price will almost always win.
Fourth, if you are uninsured and cash is tight, ask your provider whether their clinic participates in the 340B program or whether they can refer you to an FQHC in your county. The 340B price for losartan is typically $1, $3 per month [18].
The lowest documented monthly cost for losartan in West Virginia in 2026 is $0 through telehealth-bundled compounding programs, and $4 through the Walmart generic program, two viable paths for uninsured patients.
Frequently asked questions
›How much does losartan cost in West Virginia?
›Does West Virginia Medicaid cover losartan?
›Is compounded losartan legal in West Virginia?
›Can I get losartan via telehealth in West Virginia?
›Which insurance plans cover losartan in West Virginia?
›What's the cheapest way to get losartan in West Virginia?
›Are there West Virginia losartan discount programs?
›How does the Merck savings card work in West Virginia?
References
- FDA. Cozaar (losartan potassium) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020386s057lbl.pdf
- CDC. Heart Disease Mortality by State. National Center for Health Statistics. https://www.cdc.gov/nchs/pressroom/sosmap/heart_disease_mortality/heart_disease.htm
- CDC. Behavioral Risk Factor Surveillance System: Hypertension prevalence by state, 2023. https://www.cdc.gov/brfss/index.html
- Dahlöf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA Hypertension Guideline. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. https://pubmed.ncbi.nlm.nih.gov/38490803/
- Walmart Pharmacy. $4 Prescriptions Generic Drug List. https://www.walmart.com/cp/4-dollar-prescriptions/1078664
- FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations, losartan potassium. https://www.accessdata.fda.gov/scripts/cder/ob/search_product.cfm
- Schwartz AL, Landon BE, Gelb A, et al. Prescription Drug Pricing and Discount Card Use for Antihypertensives. JAMA Netw Open. 2023;6(5):e2314181. https://pubmed.ncbi.nlm.nih.gov/37195700/
- West Virginia Bureau for Medical Services. Preferred Drug List. https://www.wv.gov/
- Highmark Blue Cross Blue Shield of West Virginia. Formulary drug list 2025. https://www.highmarkbcbswv.com/
- Cubanski J, Neuman T. Medicare Part D in 2024: Changes from the Inflation Reduction Act. Kaiser Family Foundation. https://pubmed.ncbi.nlm.nih.gov/37257118/
- FDA. 503A Compounding Pharmacies. https://www.fda.gov/drugs/human-drug-compounding/503a-compounding-pharmacies
- West Virginia Board of Pharmacy. Compounding regulations. https://www.wvbop.com/
- West Virginia Legislature. WV Code 16-2I-1 et seq. Telehealth Act. https://www.wvlegislature.gov/
- Whelton PK, Carey RM, et al. ACC/AHA Hypertension Guideline 2017 (2022 update). J Am Coll Cardiol. 2018;71(19):e127. https://pubmed.ncbi.nlm.nih.gov/29146535/
- NeedyMeds. Losartan patient assistance programs. https://www.needymeds.org/
- HRSA. 340B Drug Pricing Program. https://www.hrsa.gov/opa/index.html
- Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
- Carey RM, Moran AE, Whelton PK. Treatment of Hypertension: A Review. JAMA. 2022;328(18):1849-1861. https://pubmed.ncbi.nlm.nih.gov/36282215/
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2022;79(17):e263-e421. https://pubmed.ncbi.nlm.nih.gov/35379503/